97 related articles for article (PubMed ID: 11589099)
1. [Effect of M3-choline receptor blockade on the ability of muscarinic antagonists to prevent catalepsy induced by haloperidol in rats].
Kosmachev AB; Beliaev VA; Khrabrova AV; Libman NM; Dolgo-Saburov VB
Eksp Klin Farmakol; 2001; 64(4):10-2. PubMed ID: 11589099
[TBL] [Abstract][Full Text] [Related]
2. [The antiparkinson activity of muscarinic antagonists depending on their selectivity for individual m-cholinoreceptor subtypes].
Kosmachev AB; Beliaev VA; Khrabrova AV; Fil'ko OA; Libman NM
Eksp Klin Farmakol; 1998; 61(5):3-5. PubMed ID: 9854621
[TBL] [Abstract][Full Text] [Related]
3. [The effect of selective m-cholinopositive substances on the antiparkinson activity of atropine].
Khrabrova AV; Kosmachev AB; Titkova TA; Chigarev AG
Eksp Klin Farmakol; 1999; 62(4):7-8. PubMed ID: 10513326
[TBL] [Abstract][Full Text] [Related]
4. The potency and efficacy of anticholinergics to inhibit haloperidol-induced catalepsy in rats correlates with their rank order of affinities for the muscarinic receptor subtypes.
Erosa-Rivero HB; Bata-García JL; Alvarez-Cervera FJ; Heredia-López FJ; Góngora-Alfaro JL
Neuropharmacology; 2014 Jun; 81():176-87. PubMed ID: 24534110
[TBL] [Abstract][Full Text] [Related]
5. [The role of the blockade of separate subtypes of muscarinic receptors in realizing the antidotal effect of m-cholinolytics in dimethyl dichlorovinyl phosphate poisoning].
Kosmachev AB; Beliaev VA; Fil'ko OA; Podosinovikova NP; Solov'eva NE; Titkova TA
Eksp Klin Farmakol; 1999; 62(4):55-8. PubMed ID: 10513339
[TBL] [Abstract][Full Text] [Related]
6. [The role of M-cholinoreceptor subtypes in heart rhythm disturbances of various etiology].
Kosmachev AB; Fil'ko OA; Petrov VV
Eksp Klin Farmakol; 2002; 65(1):34-6. PubMed ID: 12025782
[TBL] [Abstract][Full Text] [Related]
7. [The role of blockage of various M-cholinoreceptor subtypes in induction of tachycardia in rats].
Kosmachev AB; Lychakov AV; Saunkina IuA; Fil'ko OA; Chigareva SM
Eksp Klin Farmakol; 1997; 60(5):44-6. PubMed ID: 9483405
[TBL] [Abstract][Full Text] [Related]
8. Interaction of antidepressants with antiparkinsonian agents in rats.
Zebrowska-Lupina I; Porowska A; Pietrasiewicz T
Pol J Pharmacol Pharm; 1985; 37(6):865-74. PubMed ID: 3832020
[TBL] [Abstract][Full Text] [Related]
9. [Dynamics of vagus nerve chronotropic effect during blockage of various M-cholinoreceptors].
Osadchiĭ OE; Pokrovskiĭ VM
Biull Eksp Biol Med; 1999 Mar; 127(3):252-5. PubMed ID: 10225091
[No Abstract] [Full Text] [Related]
10. Mechanisms for metoclopramide-mediated sensitization and haloperidol-induced catalepsy in rats.
Agovic MS; Yablonsky-Alter E; Lidsky TI; Banerjee SP
Eur J Pharmacol; 2008 Jun; 587(1-3):181-6. PubMed ID: 18457824
[TBL] [Abstract][Full Text] [Related]
11. Anticataleptic effect of taurine: interaction with antiparkinsonian agents.
Zebrowska-Lupina I; Porowska A
Pol J Pharmacol Pharm; 1987; 39(4):329-35. PubMed ID: 2897118
[TBL] [Abstract][Full Text] [Related]
12. The effect of antihistaminics on cataleptogenic action of analgesics and haloperidol.
Malec D; Langwiński R
Pol J Pharmacol Pharm; 1983; 35(4):293-300. PubMed ID: 6141553
[TBL] [Abstract][Full Text] [Related]
13. [The selectivity and protective properties of m-cholinolytics in dichlorodivinylphosphate poisoning].
Kosmachev AB; Iankhotova MB; Kosmacheva IM
Eksp Klin Farmakol; 1992; 55(3):56-8. PubMed ID: 1458168
[TBL] [Abstract][Full Text] [Related]
14. Effects of 5-HT in globus pallidus on haloperidol-induced catalepsy in rats.
Wei L; Chen L
Neurosci Lett; 2009 Apr; 454(1):49-52. PubMed ID: 19429052
[TBL] [Abstract][Full Text] [Related]
15. [The evaluation of the specific activity and side effects of the m-cholinergic blocker pentifin compared to other antiparkinson agents].
Khrabrova AV; Zagrebin AO; Kosmachev AB; Kubarskaia LG; Lychakov AV; Libman NM; Savateeva TN; Titkova TA; Tonkopiĭ VD; Fil'ko OA; Khobotova ZI
Eksp Klin Farmakol; 2000; 63(2):21-3. PubMed ID: 10834089
[TBL] [Abstract][Full Text] [Related]
16. Effects of group I metabotropic glutamate receptors blockade in experimental models of Parkinson's disease.
Dekundy A; Pietraszek M; Schaefer D; Cenci MA; Danysz W
Brain Res Bull; 2006 Apr; 69(3):318-26. PubMed ID: 16564428
[TBL] [Abstract][Full Text] [Related]
17. Novel antipsychotic agents with 5-HT(1A) agonist properties: role of 5-HT(1A) receptor activation in attenuation of catalepsy induction in rats.
Kleven MS; Barret-Grévoz C; Bruins Slot L; Newman-Tancredi A
Neuropharmacology; 2005 Aug; 49(2):135-43. PubMed ID: 15996562
[TBL] [Abstract][Full Text] [Related]
18. [The role of the muscarinic receptors in the pathogenesis of the convulsive state induced by korazol in rats].
Khobotova ZI; Mukovskiĭ LA; Kosmachev AB; Fil'ko OA; Filippov VN; Dolgo-Saburov VB
Eksp Klin Farmakol; 1997; 60(1):16-8. PubMed ID: 9162273
[TBL] [Abstract][Full Text] [Related]
19. Unexpected antipsychotic-like activity with the muscarinic receptor ligand (5R,6R)6-(3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1]octane .
Bymaster FP; Shannon HE; Rasmussen K; Delapp NW; Mitch CH; Ward JS; Calligaro DO; Ludvigsen TS; Sheardown MJ; Olesen PH; Swedberg MD; Sauerberg P; Fink-Jensen A
Eur J Pharmacol; 1998 Sep; 356(2-3):109-19. PubMed ID: 9774240
[TBL] [Abstract][Full Text] [Related]
20. Caffeine and muscarinic antagonists act in synergy to inhibit haloperidol-induced catalepsy.
Moo-Puc RE; Góngora-Alfaro JL; Alvarez-Cervera FJ; Pineda JC; Arankowsky-Sandoval G; Heredia-López F
Neuropharmacology; 2003 Sep; 45(4):493-503. PubMed ID: 12907310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
